Teva Pharmaceutical Industries Limited (VIE:TEVA)
Austria
· Delayed Price · Currency is EUR 24.20
0.00 (0.00%)
At close: Dec 5, 2025
VIE:TEVA Revenue
Teva Pharmaceutical Industries had revenue of $4.48B USD in the quarter ending September 30, 2025, with 3.42% growth. This brings the company's revenue in the last twelve months to $16.78B, up 0.02% year-over-year. In the year 2024, Teva Pharmaceutical Industries had annual revenue of $16.54B with 4.40% growth.
Revenue (ttm)
$16.78B
Revenue Growth
+0.02%
P/S Ratio
1.96
Revenue / Employee
$470.10K
Employees
35,686
Market Cap
28.07B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16.54B | 698.00M | 4.40% |
| Dec 31, 2023 | 15.85B | 921.00M | 6.17% |
| Dec 31, 2022 | 14.93B | -953.00M | -6.00% |
| Dec 31, 2021 | 15.88B | -781.00M | -4.69% |
| Dec 31, 2020 | 16.66B | -228.00M | -1.35% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Erste Group Bank AG | 10.96B |
| VERBUND AG | 8.30B |
| OMV Aktiengesellschaft | 31.89B |
| Raiffeisen Bank International AG | 8.90B |
| BAWAG Group AG | 1.91B |
| Strabag SE | 17.92B |
| Vienna Insurance Group AG | 13.13B |
| Voestalpine AG | 15.29B |